Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC

J Antimicrob Chemother. 2011 Jun;66(6):1405-7. doi: 10.1093/jac/dkr117. Epub 2011 Mar 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • DNA Gyrase / genetics*
  • DNA Topoisomerase IV / genetics*
  • Drug Resistance, Bacterial
  • Escherichia coli / drug effects*
  • Escherichia coli / genetics
  • Escherichia coli Proteins / genetics*
  • Fluoroquinolones / pharmacology*
  • Humans
  • Microbial Sensitivity Tests / methods
  • Microbial Sensitivity Tests / standards
  • Mutation*

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • Fluoroquinolones
  • Qnr protein, E coli
  • DNA Topoisomerase IV
  • DNA Gyrase